Stocks and Investing Stocks and Investing
Fri, August 19, 2022
Thu, August 18, 2022

Mani Foroohar Maintained (BLUE) at Hold with Increased Target to $10 on, Aug 18th, 2022


Published on 2024-10-27 22:44:57 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "bluebird bio, Inc." (BLUE) at Hold with Increased Target from $8 to $10 on, Aug 18th, 2022.

Mani has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022


These are the ratings of the 3 analyists that currently disagree with Mani


  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $8 on, Tuesday, August 2nd, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $2 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022
Contributing Sources